» Articles » PMID: 29066921

Prevalence, Incidence Burden, and Clinical Impact of Healthcare-associated Infections and Antimicrobial Resistance: a National Prevalent Cohort Study in Acute Care Hospitals in Greece

Overview
Publisher Dove Medical Press
Date 2017 Oct 26
PMID 29066921
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Assessing the overall burden of healthcare-associated infections (HAIs) is challenging, but imperative in evaluating the cost-effectiveness of infection control programs. This study aimed to estimate the point prevalence and annual incidence of HAIs in Greece and assess the excess length of stay (LOS) and mortality attributable to HAIs, overall and for main infection sites and tracer antimicrobial resistance (AMR) phenotypes and pathogens.

Patients And Methods: This prevalent cohort study used a nationally representative cross-section of 8,247 inpatients in 37 acute care hospitals to record active HAIs of all types at baseline and overall LOS and in-hospital mortality up to 90 days following hospital admission. HAI incidence was estimated using prevalence-to-incidence conversion methods. Excess mortality and LOS were assessed by Cox regression and multistate models correcting for confounding and time-dependent biases.

Results: HAIs were encountered with daily prevalence of 9.1% (95% confidence interval [CI] 7.8%-10.6%). The estimated annual HAI incidence was 5.2% (95% CI 4.4%-5.3%), corresponding to approximately 121,000 (95% CI 103,500-123,700) affected patients each year in the country. Ninety-day mortality risk was increased by 80% in patients with HAI compared to those without HAI (adjusted hazard ratio 1.8; 95% CI 1.3-2.6). Lower respiratory tract infections, bloodstream infections, and multiple concurrent HAIs doubled the risk of death, whereas surgical site and urinary tract infections were not associated with increased mortality. AMR had significant impact on the daily risk of 90-day mortality, which was increased by 90%-110% in patients infected by carbapenem-resistant gram-negative pathogens. HAIs increased LOS for an average of 4.3 (95% CI 2.4-6.2) additional days. Mean excess LOS exceeded 20 days in infections caused by major carbapenem-resistant gram-negative pathogens.

Conclusion: HAIs, alongside with increasing AMR, pose significant burden to the hospital system. Burden estimates obtained in this study will be valuable in future evaluations of infection prevention programs.

Citing Articles

Antimicrobial resistance of bacterial pathogens isolated from cancer patients: a systematic review and meta-analysis.

Ntim O, Awere-Duodu A, Osman A, Donkor E BMC Infect Dis. 2025; 25(1):296.

PMID: 40025474 PMC: 11871764. DOI: 10.1186/s12879-025-10481-w.


Glutathione-Encoding Genes (gshA and gshB) are Associated with Oxidative Stress and Antibiotic Susceptibility in Pseudomonas aeruginosa.

Kwon D, Alsaleh S, Alharbi F, Almansour A Curr Microbiol. 2025; 82(4):138.

PMID: 39955681 DOI: 10.1007/s00284-025-04118-z.


Investigation of Healthcare-Acquired Infections and Antimicrobial Resistance in an Italian Hematology Department before and during the COVID-19 Pandemic.

Petrone F, Gizzi C, Andriani A, Martini V, Sala R, Abballe A Microorganisms. 2024; 12(7).

PMID: 39065065 PMC: 11278871. DOI: 10.3390/microorganisms12071296.


Investigation of multiple nosocomial infections using a semi-Markov multi-state model.

Zhong X, Wang D, Xiao L, Liu Y, Yang S, Mo L Antimicrob Resist Infect Control. 2024; 13(1):58.

PMID: 38845037 PMC: 11157730. DOI: 10.1186/s13756-024-01421-5.


Antimicrobial resistance of : navigating clinical impacts, current resistance trends, and innovations in breaking therapies.

Elfadadny A, Ragab R, Alharbi M, Badshah F, Ibanez-Arancibia E, Farag A Front Microbiol. 2024; 15:1374466.

PMID: 38646632 PMC: 11026690. DOI: 10.3389/fmicb.2024.1374466.


References
1.
Graves N, Weinhold D, Tong E, Birrell F, Doidge S, Ramritu P . Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007; 28(3):280-92. DOI: 10.1086/512642. View

2.
Vrijens F, Hulstaert F, Devriese S, Sande S . Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs. Epidemiol Infect. 2011; 140(1):126-36. DOI: 10.1017/S0950268811000100. View

3.
Magill S, Edwards J, Bamberg W, Beldavs Z, Dumyati G, Kainer M . Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014; 370(13):1198-208. PMC: 4648343. DOI: 10.1056/NEJMoa1306801. View

4.
Umscheid C, Mitchell M, Doshi J, Agarwal R, Williams K, Brennan P . Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011; 32(2):101-14. DOI: 10.1086/657912. View

5.
Mitchell B, Ferguson J, Anderson M, Sear J, Barnett A . Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model. J Hosp Infect. 2016; 93(1):92-9. DOI: 10.1016/j.jhin.2016.01.012. View